Display options
Share it on

Front Syst Neurosci. 2017 Oct 10;11:73. doi: 10.3389/fnsys.2017.00073. eCollection 2017.

Effects of a 5-HT.

Frontiers in systems neuroscience

Taleen S Der-Ghazarian, Tanessa Call, Samantha N Scott, Kael Dai, Samuel J Brunwasser, Sean N Noudali, Nathan S Pentkowski, Janet L Neisewander

Affiliations

  1. School of Life Sciences, Arizona State University, Tempe, AZ, United States.

PMID: 29066957 PMCID: PMC5641409 DOI: 10.3389/fnsys.2017.00073

Abstract

5-HT

Keywords: CP94253; addiction; place conditioning; sensitization; serotonin; withdrawal

References

  1. Behav Brain Res. 2012 Dec 1;235(2):105-12 - PubMed
  2. J Pharmacol Exp Ther. 2004 Nov;311(2):711-9 - PubMed
  3. Behav Brain Res. 2011 Oct 31;224(2):350-7 - PubMed
  4. Neuropharmacology. 2014 Jan;76 Pt B:301-19 - PubMed
  5. J Med Chem. 1990 Aug;33(8):2087-93 - PubMed
  6. PLoS One. 2010 Aug 16;5(8):e12141 - PubMed
  7. Psychopharmacol Bull. 2001 Autumn;35(4):170-85 - PubMed
  8. Neuropharmacology. 2007 Feb;52(2):444-9 - PubMed
  9. Addict Biol. 2010 Jul;15(3):227-49 - PubMed
  10. J Neurosci. 2011 Jul 6;31(27):9848-57 - PubMed
  11. Psychopharmacology (Berl). 2003 Jul;168(1-2):3-20 - PubMed
  12. Psychopharmacology (Berl). 2005 Mar;178(2-3):202-10 - PubMed
  13. Br J Pharmacol. 2006 Jun;148(4):405-12 - PubMed
  14. Behav Pharmacol. 2001 Apr;12(2):109-16 - PubMed
  15. J Neurosci. 2014 May 7;34(19):6659-67 - PubMed
  16. J Neurosci. 2009 Feb 25;29(8):2393-403 - PubMed
  17. Ann N Y Acad Sci. 1992 Jun 28;654:136-44 - PubMed
  18. PLoS One. 2010 Jun 09;5(6):e11038 - PubMed
  19. Biol Psychiatry. 2012 Sep 1;72(5):396-404 - PubMed
  20. Behav Pharmacol. 2004 Dec;15(8):523-34 - PubMed
  21. Pharmacol Biochem Behav. 2013 Nov;112:89-95 - PubMed
  22. Neuropharmacology. 2012 Mar;62(4):1858-66 - PubMed
  23. BMC Neurosci. 2007 Jun 21;8:42 - PubMed
  24. Eur J Neurosci. 2007 May;25(10):3125-31 - PubMed
  25. Synapse. 2013 Oct;67(10):668-77 - PubMed
  26. Psychopharmacology (Berl). 2008 Mar;197(1):145-56 - PubMed
  27. Ann N Y Acad Sci. 1995 Dec 29;771:617-25 - PubMed
  28. Pharmacol Rep. 2011;63(6):1310-5 - PubMed
  29. J Neurosci. 1998 Dec 1;18(23):10078-89 - PubMed
  30. Eur J Neurosci. 2009 Oct;30(8):1576-84 - PubMed
  31. Synapse. 1999 May;32(2):132-5 - PubMed
  32. J Neurochem. 2001 Nov;79(4):914-22 - PubMed
  33. ACS Chem Neurosci. 2014 Mar 19;5(3):168-76 - PubMed
  34. Neurosci Lett. 1986 Jun 18;67(2):113-8 - PubMed
  35. J Pharmacol Sci. 2008 Jan;106(1):15-21 - PubMed
  36. Psychopharmacology (Berl). 1993;112(2-3):163-82 - PubMed
  37. Science. 1994 Sep 23;265(5180):1875-8 - PubMed
  38. Pharmacol Biochem Behav. 2005 Feb;80(2):297-307 - PubMed
  39. Behav Brain Res. 1996;73(1-2):31-5 - PubMed
  40. Neurosci Res. 2017 Sep;122:17-24 - PubMed
  41. Eur J Pharmacol. 2007 Mar 22;559(2-3):165-72 - PubMed
  42. Eur J Pharmacol. 1987 Jul 9;139(2):205-14 - PubMed
  43. Eur Neuropsychopharmacol. 2002 Oct;12(5):387-96 - PubMed
  44. Eur Neuropsychopharmacol. 2004 May;14(3):217-25 - PubMed
  45. Psychopharmacology (Berl). 2007 Aug;193(2):295-304 - PubMed
  46. Eur J Pharmacol. 2005 May 23;516(1):46-50 - PubMed
  47. Psychopharmacology (Berl). 1999 Jan;141(3):326-31 - PubMed
  48. Int J Neuropsychopharmacol. 2017 Aug 1;20(8):644-653 - PubMed
  49. J Neurosci. 2013 Mar 6;33(10):4295-307 - PubMed
  50. Addict Biol. 2009 Sep;14(4):419-30 - PubMed
  51. Pharmacol Biochem Behav. 2002 Apr;71(4):717-25 - PubMed
  52. Pharmacol Biochem Behav. 1999 May;63(1):143-51 - PubMed
  53. J Neurosci. 2002 Dec 15;22(24):10856-63 - PubMed

Publication Types

Grant support